Share
Publications
-
/Legislation
-
12 November 2012 /Prices and reimbursement
-
21 September 2006 /Product areas
Account of the blood product area in 2005
The account contains figures about the collection of blood from donors and the use of the blood collected. The account is published annually based on figures from blood centres and the Blood-donors in Denmark.
-
20 March 2013 /Side effects and trials
Adverse drug reaction reports (ADRs) from consumers may improve patient safety
In a report, the DHMA has reviewed the ADR reports received during the years 2003–2011 to clarify how consumer reports differ from reports from healthcare professionals.
-
15 July 2005 /Prices and reimbursement
-
14 June 2010 /Authorisation and supervision
-
22 July 2011 /Authorisation and supervision
Annual report 2010 of the Danish Medicines Agency's laboratory control activities
he drug regulatory authorities in Europe cooperate in a network called the Official Medicines Control Laboratories (OMCL). The Danish Medicines Agency has published an annual report for 2010 that describes the activities of the Agency to the OMCL network.
-
16 May 2013 /Authorisation and supervision
Annual report 2011 on laboratory control activities
The medical authorities in Europe cooperate in a network called the Official Medicines Control Laboratories (OMCL). The Danish Medicines Agency has published an annual report for 2011 that describes the activities of the Agency to the OMCL network.
-
07 December 2012 /Product areas
Annual report human on tissues and cells 2011
The annual report for human tissues and cells for 2011 has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by tissue establishments and gynaecology clinics in Denmark in the period January to December 2011.
-
23 April 2010 /Prices and reimbursement
-
23 March 2011 /Prices and reimbursement
Annual report of the Reimbursement Committee 2010
In 2010, the Reimbursement Committee reviewed 20 applications for general reimbursement and 1719 applications for individual reimbursement.
-
05 March 2010 /Product areas
Annual report on human tissues and cells 2008
The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establisments and gynaecology clinics in Denmark in the period January to December 2008
-
01 November 2010 /Product areas
Annual report on human tissues and cells 2009
The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establishments and gynaecology clinics in Denmark in the period January to December 2009.
-
28 October 2011 /Product areas
Annual report on human tissues and cells 2010
The annual report for human tissues and cells for 2010 has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by tissue establishments and gynaecology clinics in Denmark in the period January to December 2010.
-
23 July 2009 /Retail and online sale
Annual report on the inspection of retail sale of OTC medicines 2008-2009
In 2008, the Danish Medicines Agency intensified its efforts on removing expired over-the-counter medicine from retail distribution.
-
24 August 2011 /Retail and online sale
Annual report on the inspection of retail sale of OTC medicines 2009-2010
In our report for 2008-2009, we made a number of critical remarks about the pharmacies' OTC outlets where we found too many deficiencies: expired medicines, possibility of self-service, medicines mixed with other goods, staff which did not know the rules, etc.
-
12 April 2007 /Prices and reimbursement
Applications for individual reimbursement of medicinal products in 2006
In 2006, the Danish Medicines Agency reviewed some 106.700 applications for single reimbursement (down 4% on 2005), apporx. 14.600 applications for reimbursement for the chronically ill (down 37 % on 2005), approx. 9.200 applications for reimbursement for the terminally ill (same level as in 2005) and approx. 2.700 applications for increased reimbursement (same level as in 2005, cf. table 1 below).
-
29 October 2010 /Side effects and trials
Assessment of safety of methylphenidate in ADHD treatment
The Danish Medicines Agency has reviewed the data on consumption and side effects of methylphenidate-containing medicine, which is authorised for the treatment of ADHD and narcolepsy.
-
30 June 2005 /Publications - miscellaneous
Better use of medicines - Perspectives in clinical pharmacy
Report by the Danish Medicines Agency’s working group on clinical pharmacy.
-
16 March 2006 /Prices and reimbursement
Changed consumption of hormones for menopausal women
The quantity consumption of hormones by women with menopausal discomfort has fallen drastically after announcements of increased risk of breast cancer. This is the finding of a consumption analysis performed by the Danish Medicines Agency on the basis of data from the Register of Medicinal Product Statistics.
